Completed Screenings April 2010 to March 2011
This table lists screenings completed from 1 April 2010 to 31 March 2011
Policy/Strategy | Completed | Screening Decision |
|---|---|---|
Bowel Cancer Screening | Apr 2010 | No EQIA |
Healthy Child, Healthy Future | Apr 2010 | No EQIA |
Dementia Strategy | May 2010 | No EQIA |
Fire & Rescue Services ( Emergencies) (Northern Ireland) Order 2010 | May 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Soft Tissue Sarcoma - Trabectedin | Apr 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Rheumatoid Arthritis – Certolizumab Pegol | Apr 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) TA 193 - Leukaemia (chronic lymphocytic, relapsed) – Rituximab | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) - NICE Cancer Services Guideline – Skin Tumours Including Melanoma | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Motor Neuron Disease – Non-invasive Ventillation | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Metastatic Malignant Disease of Unknown Origin | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Delirium | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Rheumatoid Arthritis – Tocilizumab | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Renal Cell Carcinoma (second-line metastatic) – Everolimus | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Gastrointestinal Stromal Tumours – Imatinib | July 2010 | No EQIA |
NICE Technology Appraisal – Rheumatoid Arthritis (after failure of a TNF inhibitor)– Abatacept, Adalimumab, Etanercept, Infliximab and Rituximab | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Psoriatic Arthritis – Etanercepr, Infliximab and Adalimumab | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Breast Cancer (previously treated advanced or metastatic) – Lapatinib | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Gastric Cancer (advanced) – Capecitabine | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Human Growth Hormone for Children – Somatropin | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Lung Cancer (first-line) Locally Advanced or Metastatic (non-small cell) – Gefitinib | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Lung Cancer Maintenance Treatment (non-small cell) - Pemetrexed | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Rheumatoid Arthritis – Certolizumab Pegol | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Soft Tissue Sarcoma – Trabectedin | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Hepatocellular Carcinoma – Sorafenib | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Crohn’s Disease – Infliximab (review) & Adalimumab | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Unstable Angina & NSTEMI | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Neuropathic Pain – Pharmacological Management | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Chest Pain of Recent Onset | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Donor Breast Milk Banks | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Venous Thromboembolism: Reducing the Risk | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Management of Bacterial Meningitis and Meningococcial Septicaemia in Children and Young People in Primary and Secondary Care | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Chronic Obstructive Pulmonary Disease in Adults | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Alcohol Use Disorders: Physical Complications | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Constipation in Children and Young People | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Neonatal Jaundice | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Lower Urinary Tract Infections in Men | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Glaucoma | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Clinical Guideline – Coeliac Disease | July 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) NICE technology appraisal Multiple Myeloma (first-line treatment) - Bortezomib and Thalidomide. | Sep 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) NICE technology appraisal Allergic Asthma in Children Aged 6-12 Years - Omalizumab. | Sep 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) NICE clinical guideline 107 Hypertension in Pregnancy. | Sep 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) NICE clinical guideline 108 Chronic Heart Failure | Sep 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) NICE clinical guideline 109 Transient Loss of Consciousness in Adults and Young People | Sep 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) NICE TA 200 Hepatitis C (chronic) - Peginterferon Alfa & Ribavirin | Sep 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Atrial Fibrillation – Dronedarone | Aug 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Thrombocytopenic Purpura – Eltrombopag | Oct 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Diabetes Type II - Liraglutide | Oct 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Osteoporotic Fractures in Postmenopausal Women – Denosumab | Oct 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Gastrointestinal Stromal Tumours (unresectable and/or metastatic) – Imatinib | Oct 2010 | No EQIA |
The National Institute for Health and Clinical Excellence (NICE) Technology Appraisal – Lymphocytic Leukaemia (chronic) – Ofatumumab | Oct 2010 | No EQIA |
NICE Technology Appraisal – Gastrointestinal Stromal Tumours (unresectable and/or metastatic) – Imatinib | July 2010 | No EQIA |
Next steps for a healthy start. Adding plain frozen fruit and vegetables and minimising voucher misuse. | Mar 2011 | No EQIA |
Skin Cancer Prevention Strategy & Action Plan 2010-2020. | June 2010 | No EQIA |
Review of Development Needs for Pharmaceutical Staff in Hospitals | Oct 2010 | No EQIA |
Speech, Language and Communication Therapy Action Plan – improving outcomes for children and young people with speech, language and communication needs | May 2010 | No EQIA |
Long Term Conditions Policy Framework | Jan 2011 | No EQIA |
Confidence in Care Programme - Consultation on the Pharmacy (Northern Ireland) Order 1976 (Amendment) Order (Northern Ireland) 2011 | Mar 2011 | No EQIA |
Tobacco Control Strategy for Northern Ireland | Nov 2010 | No EQIA |
Draft Physical and Sensory Disability Strategy and Action Plan (2011 – 2015) | Jan 2011 | No EQIA |
The Misuse of Drugs (Licence Fees) Regulations (Northern Ireland) 2011 | Feb 2011 | No EQIA |
The Misuse of Drugs (Safe Custody) (Amendment) Regulations (Northern Ireland) 2011 | Mar 2011 | No EQIA |
The Misuse of Drugs (Amendment) Order (Northern Ireland) 2011 | Mar 2011 | No EQIA |
Pharmacy Premises Fees Consultation 2011 | Mar 2011 | No EQIA |
